AAAAAA
Results:
1-14
|
Results: 14
Authors:
Barbeau, P
Woods, KF
Ramsey, LT
Litaker, MS
Pollock, DM
Pollock, JS
Callahan, LA
Kutlar, A
Mensah, GA
Gutin, B
Citation: P. Barbeau et al., Exercise in sickle cell anemia: Effect on inflammatory and vasoactive mediators, ENDOTHELIU, 8(2), 2001, pp. 147-155
Authors:
Kutlar, A
Citation: A. Kutlar, Proceedings of the Titus H. J. Huisman Memorial Symposium - Welcome, HEMOGLOBIN, 25(2), 2001, pp. 117-118
Authors:
Kutlar, A
Kutlar, F
Turker, I
Tural, C
Citation: A. Kutlar et al., The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease, HEMOGLOBIN, 25(2), 2001, pp. 213-217
Authors:
Adekile, AD
Kutlar, F
Haider, MZ
Kutlar, A
Citation: Ad. Adekile et al., Frequency of the 677 C -> T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients, AM J HEMAT, 66(4), 2001, pp. 263-266
Authors:
Orringer, EP
Casella, JF
Ataga, KI
Koshy, M
Adams-Graves, P
Luchtman-Jones, L
Wun, T
Watanabe, M
Shafer, F
Kutlar, A
Abboud, M
Steinberg, M
Adler, B
Swerdlow, P
Terregino, C
Saccente, S
Files, B
Ballas, S
Brown, R
Wojtowicz-Praga, S
Grindel, JM
Citation: Ep. Orringer et al., Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease - A randomized controlled trial, J AM MED A, 286(17), 2001, pp. 2099-2106
Authors:
Araten, DJ
Swirsky, D
Karadimitris, A
Notaro, R
Nafa, K
Bessler, M
Thaler, HT
Castro-Malaspina, H
Childs, BH
Boulad, F
Weiss, M
Anagnostopoulos, N
Kutlar, A
Savage, DG
Maziarz, RT
Jhanwar, S
Luzzatto, L
Citation: Dj. Araten et al., Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria, BR J HAEM, 115(2), 2001, pp. 360-368
Authors:
Woods, KF
Johnson, JA
Kutlar, A
Daitch, L
Stachura, ME
Citation: Kf. Woods et al., Sickle cell disease telemedicine network for rural outreach, J TELEMED T, 6(5), 2000, pp. 285-290
Authors:
Valafar, H
Valafar, F
Darvill, A
Albersheim, P
Kutlar, A
Woods, KF
Hardin, J
Citation: H. Valafar et al., Predicting the effectiveness of hydroxyurea in individual sickle cell anemia patients, ARTIF INT M, 18(2), 2000, pp. 133-148
Authors:
Jillella, AP
Kallab, AM
Kutlar, A
Citation: Ap. Jillella et al., Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options, BONE MAR TR, 26(8), 2000, pp. 925-927
Authors:
Woods, KF
Onuoha, A
Schade, RR
Kutlar, A
Citation: Kf. Woods et al., Helicobacter pylori infection in sickle cell disease, J NAT MED A, 92(7), 2000, pp. 361-365
Authors:
Woods, KF
Kutlar, A
Johnson, JA
Waller, JL
Grigsby, RK
Stachura, ME
Rahn, DW
Citation: Kf. Woods et al., Sickle cell telemedicine and standard clinical encounters: A comparison ofpatient satisfaction, TELEMED J, 5(4), 1999, pp. 349-356
Authors:
Tadmouri, GO
Bilenoglu, O
Kutlar, F
Markowitz, RB
Kutlar, A
Basak, AN
Citation: Go. Tadmouri et al., Identification of the Chinese IVS-II-654 (C -> T) beta-thalassemia mutation in an immigrant Turkish family: Recurrence or migration?, HUMAN BIOL, 71(2), 1999, pp. 295-302
Authors:
Woods, K
Kutlar, A
Grigsby, RK
Adams, L
Stachura, ME
Citation: K. Woods et al., Primary-care delivery for sickle cell patients in rural Georgia using telemedicine, TELEMED J, 4(4), 1998, pp. 353-361
Authors:
Tuohy, AMM
McKie, VC
Sabio, H
Kutlar, F
Kutlar, A
Wilson, JB
Citation: Amm. Tuohy et al., Hb Hammersmith [beta 42(CD1)Phe -> Ser]: Occurrence as a de novo mutation in black monozygotic twins with multiple congenital anomalies, J PED H ONC, 20(6), 1998, pp. 563-566
Risultati:
1-14
|